Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 6N4FA2QQ6A |
InChI Key | QZPQTZZNNJUOLS-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H14O3 |
Molecular Weight | 242.27 |
AlogP | 2.75 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 43.37 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 18.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | 1200-1900 | - | 109 | 10 | |
Enzyme
Oxidoreductase
|
- | 440-1000 | - | 100-100 | - | |
Enzyme
Phosphodiesterase
|
- | 970 | - | - | - | |
Enzyme
Transferase
|
- | 120 | - | - | - | |
Enzyme
|
- | 440-1000 | - | 100-100 | 10 | |
Epigenetic regulator
Eraser
Lysine demethylase
Jumonji domain-containing
|
- | 3000-3000 | - | 3550 | - | |
Other cytosolic protein
|
- | 2100 | - | - | - | |
Transcription factor
|
- | 4000 | - | - | - | |
Unclassified protein
|
- | 590-1300 | - | - | 77-99 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 2 | D009369 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Carcinoma | 1 | D002277 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 10429 |
ChEMBL | CHEMBL15192 |
DrugBank | DB11948 |
EPA CompTox | DTXSID90197019 |
FDA SRS | 6N4FA2QQ6A |
KEGG | C10367 |
PubChem | 3885 |
SureChEMBL | SCHEMBL107042 |
ZINC | ZINC000001531790 |